Association of biological characteristic of leukemia cells with outcomes of patients with Acute Leukemia: a prospective study

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047266

Enrollment

Unknown

Registered

2021-06-11

Start date

2021-06-20

Completion date

Unknown

Last updated

2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute leukemia

Interventions

Experimental group:chemotherapy and/ or hematopoietic stem cell transplantation

Eligibility

Sex/Gender

All

Age

8 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Newly diagnoses and/ or allogeneic stem cell transplantation candidates with acute leukemia; 2.Aged 8 to 60 years; 3.Subjects are able to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1.Subjects who cannot comply with the study; 2.Subjects with severe cardiac disease (ejection fraction34umol/L, ALT and AST>1.5xupper limit normal) or kidney disease (Serum creatinine>130umol/L); 3.Subjects with severe infection;4)Subjects with other conditions that cannot receive chemotherapy or transplantation.

Design outcomes

Primary

Measure	Time frame
Relapse rate;Not dependent on blood transfusion;	—

Countries

China

Contacts

Public ContactChang Yingjun

Peking University People's Hospital & Peking University Institute of Hematology

rmcyj@bjmu.edu.cn+86 10 88325949

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026